Adequacy of current postglucose GH nadir limit (< 1 μg/l) to define long-lasting remission of acromegalic disease

Clinical Endocrinology

Volumn 66, Issue 4, 2007, Pages 538-542

  Ronchi, Cristina L ^a,b   Arosio, Maura ^a,c   Rizzo, Erica ^a,b   Lania, Andrea G ^a,b   Beck Peccoz, Paolo ^a,b   Spada, Anna ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ACROMEGALY; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; HYPOPHYSIS FUNCTION; INSULIN SENSITIVITY; MALE; METABOLIC PARAMETERS; MONITORING; NEURORADIOLOGY; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY;

ACROMEGALY; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; MALE; MIDDLE AGED; REFERENCE VALUES; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 33947210193     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02769.x     Document Type: Article

References (24)

1. Growth Hormone Research Society & Pituitary Society (2004) Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society. Journal of Clinical Endocrinology and Metabolism, 89, 3099-3102.
2. Giustina, A., Barman, A., Casanueva, F.F., Cavagnini, F., Frohman, L., Ho, K., Veldhuis, J., Wass, J., Von Werder, K. & Melmed, S. (2000) Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 85, 526-529.
3. Freda, P.U., Post, K.D., Powell, J.S. & Wardlaw, S.L. (1998) Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3808-3816.
4. Freda, P.U. (2003) Current concepts in the biochemical assessment of the patient with acromegaly. Growth Hormone and IGF Research, 13, 171-184.
5. Serri, O., Beauregard, C. & Hardy, J. (2004) Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 658-661.
6. Gullu, S., Keles, H., Delibasi, T., Tonyukuk, V., Kamel, N. & Erdogan, G. (2004) Remission criteria for the follow-up of patients with acromegaly. European Journal of Endocrinology, 150, 465-471.
7. Freda, P.U., Nuruzzaman, A.T., Reyes, C.M., Sundeen, R.E. & Post, K.D. (2004) Significance of 'abnormal' nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. Journal of Clinical Endocrinology and Metabolism, 89, 495-500.
8. Costa, A.C.F., Rossi, A., Martinelli, C.E., Machado, H.R. & Moreira, A.C. (2002) Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure? Journal of Clinical Endocrinology and Metabolism, 87, 3142-3147.
9. Minniti, G., Jaffrain-Rea, M.L., Esposito, V., Santoro, A., Tamburrano, G. & Cantore, G. (2003) Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature. Endocrine Related Cancer, 10, 611-619.
10. Takahashi, J.A., Shimatsu, A., Nakao, K. & Hashimoto, N. (2004) Early postoperative indicators of late outcome in acromegalic patients. Clinical Endocrinology, 60, 366-374.
11. De Marinis, L., Mancini, A., Bianchi, A., Gentilella, R., Valle, D., Giampietro, A., Zuppi, P., Anile, C., Maira, G. & Giustina, A. (2002) Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. Metabolism, 51, 616-621.
12. Ronchi, C.L., Varca, V., Giavoli, C., Epaminonda, P., Beck-Peccoz, P., Spada, A. & Arosio, M. (2005) Long-term evaluation of postoperative acromegalic patients in remission with previous and newly proposed criteria. Journal of Clinical Endocrinology and Metabolism, 90, 1377-1382.
13. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia, 28, 412-419.
14. Katz, A., Nambi, S.S. & Mather, K. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism, 85, 2402-2410.
15. Expert Panel on Detection, Evaluation, and Treatment of high blood cholesterol in Adults (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (ATPIII). Journal of American Medical Association, 287, 356-359.
16. World Health Organization (1999) Definition, Diagnosis and Classi-fication of Diabetes Mellitus and its Complications. Report of a WHO consultation, Part 1. Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva, Switzerland.
17. Epaminonda, P., Porretti, S., Cappiello, V., Faglia, G. & Arosio, M. (2001) Efficacy of radiotherapy in normalizing serum IGF-I, acid-labil subunit (ALS) and IGF-BP3 levels in acromegaly. Clinical Endocrinology, 55, 183-189.
18. Puder, J.J., Nilavar, S., Post, K.D. & Freda, P.U. (2005) Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 90, 1972-1978.
19. Iranmanesh, A., Lizarralde, G. & Veldhuis, J.D. (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism, 73, 1081-1088.
20. Williams, T., Berelowitz, M., Joffe, S.N., Thorner, M.O., Rivier, J., Vale, W. & Frohman, L.A. (1984) Impaired growth hormone responses to growth hormone-releasing factor in obesity: a pituitary defect reversed with weight reduction. New England Journal of Medicine, 311, 1403-1407.
21. Vierhapper, H., Heinze, G., Gessl, A., Exner, M. & Bieglmayr, C. (2003) Use of the oral glucose tolerance test to define remission in acromegaly. Metabolism, 52, 181-185.
22. Mukherjee, A., Murray, R.D. & Shalet, S.M. (2004) Impact of growth hormone status on body composition and the skeleton. Hormone Research, 62 (Suppl. 3), 35-41.
23. Conceicao, F.L., Fisker, S., Andersen, M., Kaal, A., Jorgensen, J.O., Vaisman, M. & Christiansen, J.S. (2003) Evaluation of growth hormone stimulation tests in cured acromegalic patients. Growth Hormone and IGF Research, 13, 347-352.
24. Murray, R.D., Peacey, S.R., Rahim, A., Toogood, A.A., Thorner, M.O. & Shalet, S.M. (2001) The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients. Clinical Endocrinology, 54, 37-44.